Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.

Inclusion Criteria

• •Male or female subject.
• •Aged 18 to 75 years
• •With a planned surgery:
• •Of abdominal location
• •Leading to an acute wound of a maximum total length ≤ 18 cm (corresponding to 2 investigational products)
• •Absence of clinical sign suggestive of worsened wound (assessed only at the randomization visit)
• •Followed-up in surgery department
• •Written and signed informed consent obtained
• •Affiliated to the French Social Security system or equivalent.
• •Inadequately controlled diabetes (Glycosylated hemoglobin \> 8%)
• •Hypo or hyperthyroidism
• •Intake of a systemic treatment with glucocorticoids or immunosuppressives
• •Known allergy to one of study dressings components
• •Participation in a clinical trial in the month prior to his/her inclusion in the study
• •Pregnancy or breastfeeding or of childbearing potential and saying not to use contraception.